Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
HIV Clinical Trials|June 3, 2009
Low-level viremia in HIV-1 infection: consequences and implications for switching to a new regimenCalvin Cohen
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 16, 2011
Cost-effectiveness of nucleoside reverse transcriptase inhibitor pairs in efavirenz-based regimens for treatment-naïve adults with HIV infection in the United StatesAnita J Brogan, Sandra E Talbird, Calvin Cohen
The AIDS Reader|March 21, 2003
Improving adherence to antiretroviral therapyEric S Daar, Calvin Cohen, Robert Remien, et al.
AIDS Research and Treatment|November 30, 2012
Cost-Effectiveness of Antiretroviral Therapy for Multidrug-Resistant HIV: Past, Present, and FutureMarianne Harris, Bohdan Nosyk, Richard Harrigan, et al.
HIV Clinical Trials|October 30, 2003
Patient acceptance of self-injected enfuvirtide at 8 and 24 weeksCalvin Cohen, James Hellinger, Margaret Johnson, et al.
Antiviral Therapy|December 19, 2002
Efficacy and safety of twice-daily versus three-times daily saquinavir soft gelatin capsules as part of triple combination therapy for HIV-1 infectionL Joseph Wheat, Charles Farthing, Calvin Cohen, et al.
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)|August 29, 2003
Once-daily antiretroviral therapies for HIV infection: Consensus Statement of an Advisory Committee of the International Association of Physicians in AIDS CareCalvin Cohen, Richard A Elion, Ian Frank, et al.
HIV Clinical Trials|December 4, 2010
Similar virologic and immunologic efficacy with fosamprenavir boosted with 100 mg or 200 mg of ritonavir in HIV-infected patients: results of the LESS trialCalvin Cohen, Edwin Dejesus, Anthony Lamarca, et al.
HIV Clinical Trials|June 29, 2005
Pilot study of saquinavir and lopinavir/ritonavir twice daily in protease inhibitor-naive HIV-positive patientsJames Hellinger, Calvin Cohen, Anne Morris, et al.
HIV Clinical Trials|January 9, 2007
Once-daily abacavir/lamivudine/zidovudine plus tenofovir for the treatment of HIV-1 infection in antiretroviral-naïve subjects: a 48-week pilot studyRichard Elion, Calvin Cohen, Edwin DeJesus, et al.
Pageof 4